Contributions of CD8+ T cells and viral spread to demyelinating disease

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 4080-4088

  Marten, Norman W ^a   Stohlman, Stephen A ^a   Atkinson, Roscoe D ^a   Hinton, David R ^a   Fleming, John O ^b   Bergmann, Cornelia C ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MCH 142 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; IMMUNOCOMPETENCE; IMMUNOPATHOGENESIS; MALE; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; SYMPTOM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0034655165     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.4080     Document Type: Article

References (63)

1. Lane, T. E., and M. J. Buchmeier. 1997. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol. 5:9.
2. Stohlman, S. A., C. C. Bergmann, and S. Perlman. 1999. Mouse hepatitis virus. In Persistent Viral Infections. R. Ahmed and I. Chen, eds. John Wiley & Sons, New York, p. 537.
3. Houtman, J. J., and J. O. Fleming. 1996. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J. Neurovirol. 2:101.
4. Houtman, J. J., and J. O. Fleming. 1996. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:361.
5. Wang, F. I., S. A. Stohlman, and J. O. Fleming. 1990. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 30:31.
6. Williamson, J. S. P., and S. A. Stohlman. 1990. Effective clearance of mouse hepatitis virus from the central nervous system. J. Virol. 64:4589.
7. Williamson, J. S. P., K. Sykes, and S. A. Stohlman. 1991. Characterization of brain infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32:199.
8. Fleming, J. O., C. Adami, J. Pooly, J. Glomb, E. Stecker, F. Fazal, and S. C. Baker. 1995. Mutations associated with viral sequences isolated from mice persistently infected with MHV-JHM. Adv. Exp. Med. Biol. 380:591.
9. Stohlman, S. A., C. C. Bergmann, R. van der Veen, and D. R. Hinton. 1995. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69: 684.
10. Sussman, M., R. Shubin, S. Kyuwa, and S. A. Stohlman. 1989. T cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J. Virol. 63:3051.
11. + T cells during viral persistence in the CNS. J. Immunol. 63:3379.
12. Castro, R. F., and S. Perlman. 1996. Differential antigen recognition by T cells from the spleen and central nervous system of coronavirus-infected mice. Virology 222:247.
13. Stohlman, S. A., S. Kyuwa, J. M. Polo, D. Brady, M. C. Lai, and C. C. Bergmann. 1993. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J. Virol. 67:7050.
14. Lin, M. T., S. A. Stohlman, and D. R. Hinton. 1997. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 71:383.
15. + T cells. J. Immunol. 160:2896.
16. Lin, M. T., D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman. 1999. Antibody prevents virus reactivation within the central nervous system. J. Immunol. 162:7358.
17. + T cells. Microb. Pathog. 18:211.
18. + T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J. Neurovirol. 3:225.
19. Xue, S., N. Sun, N. van Rooijen, and S. Perlman. 1999. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J. Virol. 73:6327.
20. Lampert, P. W., J. K. Sims, and A. J. Kniazeff. 1973. Mechanism of demyelination in JHM virus encephalomyelitis: electron microscopic studies. Acta Neuropathol. 24:76.
21. + cells to demyelination induced by coronavirus JHM. Regul. Immunol. 5:37.
22. + T cell responses in the central nervous system of mice infected with mouse hepatitis virus. Virology 238:68.
23. Stohlman, S. A., P. R. Braton, J. O. Fleming, L. P. Weiner, and M. C. Lai. 1982. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. Gen. Virol. 63:265.
24. Fazakerley, J. F., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187:178.
25. Fleming, J. O., M. Trousdale, F. E. Zactarim, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of mutine coronavirus JHM selected with mAb. J. Virol. 58:869.
26. Parker, S. E., T. M. Gallagher, and M. J. Buchmeier. 1989. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 174:664.
27. Wang, F. I., J. O. Fleming, and M. C. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology 186:742.
28. b-restricted cytotoxic T cell response. J. Gen. Virol. 77:315.
29. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127.
30. d-restricted cytotoxic T lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J. Virol. 67:7041.
31. Fleming, J. O., R. A. Shubin, M. A. Sussman, N. Casteel, and S. A. Stohlman. 1989. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168:162.
32. Parra, B., D. R. Hinton, N. W. Marten C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-γ is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641.
33. Fleming, J. O., S. A. Stohlman, R. C. Harmon, M. M. C. Lai, J. A. Frelinger, and L. P. Weiner. 1983. Antigenic relationship of murine coronavirus: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology 131:296.
34. Stohlman, S. A., C. C. Bergmann, D. Cua, H. Wege, and R. van der Veen. 1994. Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology 202:146.
35. + T cells with a highly focused specificity during viral persistence in the central nervous system. J. Immunol. 162:3905.
36. d-restricted cytotoxic T lymphocyte response to the mouse hepatitis virus nucleocapsid protein. J. Virol. 70:3252.
37. Williamson, J. S. P. 1992. Virus-specific T cells in the central nervous system following infection with an avirulent neurotropic mouse hepatitis virus. Regul. Immunol. 4:145.
38. Parra, B., D. R. Hinton, M. T. Lin, D. J. Cua, and S. A. Stohlman. 1997. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 233:260.
39. Aichele, P., M. F. Bachmann, H. Hengartner, and R. M. Zinkernagel. 1996. Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol. Rev. 152:21.
40. Hawke, S., P. G. Stevenson, S. Freeman, and C. R. M. Bangham. 1998. Longterm persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J. Exp. Med. 187:1575.
41. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
42. Cserr. H. F., and P. M. Knopf. 1992. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 13:507.
43. Drescher, K. M., L. R. Pease, and M. Rodriguez. 1997. Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol. Rev. 159:177.
44. Fabry, Z., C. S. Raine, and M. N. Hart. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218.
45. Fontana, A., K. Frei, S. Bodmer, and E. Hofer. 1987. Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue. Immunol. Rev. 100: 185.
46. Gehrman, J., Y. Matsumoto, and G. W. Kreutzberg. 1995. Microglia: intrinsic immunoeffector cell of the brain. Brain Res. Rev. 20: 269.
47. Renno, T., V. Taupin, L. Bournonniere, G. Verge, E. Tran, R. DeSimone, M. Krakowski, M. Rodriguez, A. Peterson, and T. Owens. 1998. Interferon-γ in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 12:376.
48. Yauch, R. L., J. P. Palma, H. Yahikozawa, C.-S. Koh, and B. S. Kim. 1998. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 72:6169.
49. Horwitz, M. S., C. F. Evans, D. B. McGavern, M. Rodriguez, and M. B. A. Oldstone. 1997. Primary demyelination in transgenic mice expressing interferon-γ. Nat. Med. 3:1037.
50. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott. H. Hengartner, and R. Zinkernagel, 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383.
51. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
52. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. D. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral Immune evasion due to persistence of activated cells without effector function. J. Exp. Med. 188:2205.
53. Perry, V. H., M. D. Bell, H. C. Brown, and M. K. Matyszak. 1995. Inflammation in the nervous system. Curr. Opin. Neurobiol 5:636.
54. Probert, L., K. Akassolglou, G. Kassiotis, M. Pasparakis, L Alexopoulou, and G. Kollias. 1997. TNF-α transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:137.
55. Stohlman, S. A., D. R. Hinton, D. Cua, E. Dimacali, J. Sensintaffar, F. M. Hofman, S. M. Tahara, and Q. Yao. 1995. Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J. Virol. 69:5898.
56. + cytolytic T cells against mouse hepatitis virus A59. Immunology 84:521.
57. Murray, P. D., D. B. McGavern, Lin, X., M. K. Njenga, J. Leibowitz, L. R. Pease, and M. Rodriguez. 1998. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18:7306.
58. + T cells contribute to tissue destruction during Borna disease. J. Immunol. 153:818.
59. + T cells. Immunol. Today 11:55.
60. Elovaara, I., S. Koenig, A. Y. Brewah, R. M. Woods, T. Lehky, and S. Jacobson. 1993 High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 177:1567.
61. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
62. + T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 67:7629.
63. Wang, F. I., D. R. Hinton, W. Gilmore, M. D. Trousdale, and J. O. Fleming. 1992. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab. Invest. 66:744.